This week is Nursing Week and is an opportunity to highlight the many accomplishments being made in the field-and the remarkable people making advances and changes in such a dynamic profession.Pauline Voonis one of those remarkables: she applies her breadth of education and experience in nursing to research.
This is a success story from the STOP HIV/AIDS, a program of Vancouver Coastal Health based on the Treatment as Prevention¨ model of providing immediate and universal access to HIV treatment for all diagnosed. The STOP Team reaches out to vulnerable and hard-to-reach populations..
From Little Hope to Remarkable Change: A Success Story from the STOP HIV/AIDS¨ Team Read More »
A recent BC Centre of Excellence in HIV/AIDS (BC-CfE) study observed trends among HIV-positive patients admitted to St. Paul’s Hospital between 2005 and 2014, finding respiratory infections and opportunistic infections were the top discharge diagnoses.
This week marks Youth Week in British Columbia. Globally, there have never been more young people than there are today: as of 2009, there are an estimated 1.8 billion people ages 10 to 24. These are the leaders of tomorrow, and will be the ones to determine the health and wellbeing of the next generation.
HIV-Positive Youth: Linking Them to Early Treatment Essential for Long-Term Health Read More »
The Clinical Education and Training Program at the BC Centre for Excellence in HIV/AIDS (BC-CfE) has launched a new website that serves as an easy-to-access portal to valuable informational and scholarly resources. Created to provide educational information regarding HIV to clinicians and health care professionals in BC, the site has a wealth of free tools
New online portal to HIV education resources Read More »
September 17, 2012 – The Pharmacovigilance Program at the BC Centre for Excellence in HIV/AIDS has received reports of patients seeing nevirapine 400 mg XR (extended release) tablets or tablet fragments in their feces (stools). In BC, approximately 4% of patients treated with nevirapine XR have reported seeing tablet remnants in their stool. Nevirapine 400
SAFETY UPDATE: Nevirapine 400 mg XR (Viramune XR™) tablet remnants in feces Read More »
June 6, 2011 – The Pharmacovigilance Program at the BC Centre for Excellence in HIV/AIDS has reviewed the following incident: On May 11, 2011, Janssen Inc. issued an advisory that some bottles of darunavir (Prezista TM) 600 mg tablets in Lot # ALZ0J00 might have an uncharacteristic “musty” or “mouldy” odour caused by trace quantities
SAFETY ALERT: DARUNAVIR (PREZISTA TM) Read More »
A key component of the Centre’s mandate is to monitor the impact of HIV/AIDS on British Columbia. The BC-CfE provides essential information to local health authorities, treating physicians and the community-at-large on an ongoing basis. The Drug Treatment Program Update is one example of the Centre’s commitment. In B.C., all anti-HIV medications are distributed at
Drug Treatment Program Update (April 2011) Read More »
New cases of HIV among those who use drugs by injection continue to decline in B.C., according to a report by the provincial health officer. A major factor in the decline has been the expansion of Highly Active Anti-retroviral Therapy (HAART) and harm reduction programs, says the report. Introduced in 1997, HAART is a combination
New HIV cases drop among injection drug users in BC Read More »
The Chinese government has announced it will use a treatment strategy developed in B.C. to combat the spread of HIV and AIDS in China. The country has 740,000 people infected with HIV and a further 110,000 with AIDS. The “treatment as prevention” model being adopted by China was pioneered by the BC Centre for Excellence
B.C.-developed strategy to combat HIV spread in China Read More »
